[ Price : $8.95]
FDA approves an Eli Lilly NDA for Inluriyo (imlunestrant, 200 mg tablets), an oral estrogen receptor antagonist for treating certa...[ Price : $8.95]
CBER posts 13 Form FDA-483s under the Freedom of Information Acts provision on frequently requested records.[ Price : $8.95]
FDA grants Biolinq a de novo authorization for its Shine system, said to be the first fully autonomous, needle-free glucose sensor...[ Price : $8.95]
HHS secretary Robert F. Kennedy, Jr., says FDA is reviewing safety evidence relating to the medication abortion drug mifepristone.[ Price : $8.95]
FDA says the Risk Evaluation and Management Strategy program that has been in place since 2011 for Sanofis thyroid cancer drug Cap...[ Price : $8.95]
FDA warns Dr. Ralph DeFronzo about violations in his work as a clinical investigator for two trial protocols at the University of ...[ Price : $8.95]
Harmony Biosciences reports topline results from a Phase 3 registrational clinical trial of ZYN002 in Fragile X syndrome did not m...[ Price : $8.95]
FDA posts a draft guidance outlining methods drugmakers should use to collect long-term safety and efficacy data once cell and gen...